<DOC>
	<DOCNO>NCT00362622</DOCNO>
	<brief_summary>To determine association medical , demographic , socioeconomic , therapeutic difference compliance topical glaucoma therapy use Travalert device .</brief_summary>
	<brief_title>Determinants Compliance With Glaucoma Therapy</brief_title>
	<detailed_description>To determine association medical , demographic , socioeconomic , therapeutic difference compliance topical glaucoma therapy use Travalert device . All participant open angle glaucoma .</detailed_description>
	<mesh_term>Glaucoma</mesh_term>
	<mesh_term>Glaucoma , Open-Angle</mesh_term>
	<criteria>To eligible participate study , patient ( 1 ) 19 year old ; ( 2 ) diagnosis open angle glaucoma ( OAG ) 1 eye ocular hypertension ; ( 3 ) use prostaglandin ocular hypotensive medication 1 eye . The protocol exclude patient uncontrolled IOP control , know contraindication Travoprost , clinically significant systemic disease would interfere study , participation research study within 30 day , change systemic medication may alter IOP within 30 day recruitment .</criteria>
	<gender>All</gender>
	<minimum_age>19 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>August 2012</verification_date>
	<keyword>Travalert</keyword>
	<keyword>open angle glaucoma</keyword>
</DOC>